CBp aims to foster understanding of the role biopharmaceuticals and the industry as a whole will play in Caribbean healthcare systems. As a blog-based forum it seeks to achieve this by disseminating content on the subject and encouraging dialogue between stakeholders.
CBp’s mission to encourage dialogue implies two-way communication. As such our website is built upon the premise of community where members will contribute feedback on articles and will themselves be invited to post. We encourage you to do so vigorously.
Given the critical importance of regulation to transparency and safety in the industry we will endeavour to compile and share up-to-date contact information for regulatory bodies and associations within the region.
The rapid pace at which the biopharma industry is developing warrants that cutting-edge information and guidelines from regulators be made available. CBp will endeavour to place this information at your finger-tips.
Download e-documents and e-books relevant to the biopharmaceutical industry from the CBp Download Store.
Don’t miss out on these featured posts from the CBp Blog!!! Click the images below to view the corresponding post
Biopharmaceutical Stability, Storage & Handling
Learn about the highly sensitive nature of biopharmaceuticals, the factors that affect their physical stability and why strict storage conditions are critical to preserving their usefulness and safety.
Biopharmaceutical Protein Structure 1
The vast majority of biopharmaceuticals are proteins. As such appreciating protein structure is fundamental to understanding their behaviour and peculiarities as a drug class. This post builds a foundation for understanding the 4 levels of protein structure.
Biopharmaceutical Protein Structure 2
This second post in the 2-part series on protein structure goes to the next level looking at the 4-levels of protein structure and what they mean for the behaviour of proteins and protein-based drugs.
What is a Biopharmaceutical? (Part I): The Role of Genetic Engineering
Genetic Engineering (GE) plays a central role in the development and manufacture of biopharmaceuticals. As such this post explores this role giving the reader an appreciation of just how delicate both process and resulting product are.
Share this Page
Featured CBp Downloads
Featured Regional Regulators
MoH, Trinidad & Tobago
MoH, The Bahamas
MoH, The Cayman Islands
Featured Global Regulators
The World Health Organization
The International Conference on Harmonization
The European Medicines Agency
The United States Food & Drug Administration
Are you a pharmacist, pharmacologist or pharma industry insider? Enjoy writing? Curious to find out if you do?
We’re looking for content contributors. Tell us through our Contact Form if you think you are ready to be one.
Call for Abstracts
Are you a researcherin pharmaceutical science or a related discipline? Need a space to highlight your hard work? We can help so tell us through our Contact Form.
We need your help!!!
Do you have contact information for pharmaceutical associations and authorities in your Caribbean country? Help us gather and share this vital information with pharmaceutical professionals in the region. Tell us through our Contact Form.